Filtros de búsqueda

Lista de obras de David M. Gershenson

4-HPR modulates gene expression in ovarian cells

artículo científico

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma ⬇️

artículo científico publicado el 2 de agosto de 2010

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

artículo científico publicado en 2004

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

artículo científico publicado en 2009

A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer.

artículo científico publicado en 2006

A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary

scientific article published on 09 February 2007

Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type

scientific article published on 19 April 2018

Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience.

artículo científico publicado en 2017

Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors

artículo científico publicado en 2018

Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors

artículo científico publicado en 2014

Adult granulosa cell tumors of the ovary in two first-degree relatives

artículo científico publicado en 2005

An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients

artículo científico publicado en 2004

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

artículo científico

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

artículo científico publicado en 2019

Analysis of EphA2 expression and mutant p53 in ovarian carcinoma

artículo científico publicado en 2006

Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors

artículo científico publicado en 2009

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

artículo científico publicado en 2009

Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma

artículo científico publicado en 2006

Antitumor and antivascular effects of AVE8062 in ovarian carcinoma

artículo científico publicado en 2007

Association between adiponectin, insulin resistance, and endometrial cancer

scientific article published on 01 June 2006

Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3

artículo científico publicado en 2012

Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast

scientific article published on 01 May 2002

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

artículo científico publicado en 2010

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion

artículo científico publicado en 2004

Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome

artículo científico publicado en 2004

CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.

artículo científico publicado en 2013

Calcifications in ovary and endometrium and their neoplasms

artículo científico publicado en 2003

Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study

artículo científico publicado en 2008

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series.

artículo científico publicado en 2015

Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.

artículo científico publicado en 2009

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

artículo científico publicado en 2006

Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma

artículo científico publicado en 2006

Classification of ovarian cancer: a genomic analysis.

artículo científico publicado en 2008

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

artículo científico publicado en 2010

Clinical and biological significance of vascular endothelial growth factor in endometrial cancer

artículo científico publicado en 2007

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

artículo científico publicado en 2006

Clinical management potential tumours of low malignancy

artículo científico publicado en 2002

Clinical trial methodology in rare gynecologic tumor research: Strategies for success.

artículo científico publicado en 2018

Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma

artículo científico publicado en 2011

Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma

artículo científico publicado en 2007

Complete Resection Is Essential in the Surgical Treatment of Gestational Trophoblastic Neoplasia

scientific article published on 01 October 2018

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival

artículo científico publicado en 2022

Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment.

artículo científico publicado en 2016

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

scientific article published on 01 May 2019

Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

article

Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway

scientific article published on 01 June 2007

Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary ⬇️

artículo científico publicado el 14 de marzo de 2012

DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry

artículo científico publicado en 2017

Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy

artículo científico publicado en 2004

Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study

artículo científico publicado en 2020

Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations

scientific article published on 26 November 2020

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.

artículo científico publicado en 2017

Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma

artículo científico publicado en 2019

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

artículo científico publicado en 2006

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group ⬇️

artículo científico publicado el 24 de octubre de 2013

Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum

artículo científico publicado en 2008

Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors

artículo científico publicado en 2020

Endometrial cancer in young, normal-weight women

artículo científico publicado en 2005

Epithelial Ovarian Cancer ⬇️

artículo científico publicado el 1 de enero de 2011

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations Missed Opportunities

scholarly article by Larissa A. Meyer et al published July 2010 in Obstetrical and Gynecological Survey

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities

artículo científico publicado en 2010

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results ⬇️

artículo científico publicado el 1 de mayo de 2003

Evolving population-based statistics for rare epithelial ovarian cancers

artículo científico publicado en 2020

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

artículo científico publicado en 2003

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma

artículo científico publicado en 2004

Expression of metastasis-related genes in human epithelial ovarian tumors

artículo científico publicado el 1 de enero de 2002

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines

artículo científico publicado en 2004

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary

artículo científico publicado en 2005

Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer

artículo científico publicado en 2015

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper

artículo científico publicado en 2017

Fallopian tube cancer: stepchild or mother?

scientific article published on 01 December 2007

Fertility preservation in rare ovarian tumors

artículo científico publicado en 2021

Fertility-sparing surgery for malignancies in women

artículo científico publicado en 2005

Fertility-sparing therapy for young women with endometrial cancer

artículo científico publicado en 2006

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

artículo científico publicado en 2005

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

artículo científico publicado en 2006

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity

artículo científico publicado en 2004

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

artículo científico publicado en 2024

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

artículo científico publicado en 2007

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

article

Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome

artículo científico publicado en 2012

Grading ovarian serous carcinoma using a two-tier system

scientific article published on 01 April 2004

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).

artículo científico publicado en 2014

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome

artículo científico publicado en 2005

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

artículo científico publicado en 2008

Healthcare reform: it's time

artículo científico publicado en 2009

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

artículo científico publicado en 2004

Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum

artículo científico publicado en 2017

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum ⬇️

artículo científico publicado el 6 de marzo de 2012

Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas

artículo científico publicado en 2005

Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.

artículo científico publicado en 2015

Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.

artículo científico publicado en 2017

Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum.

artículo científico publicado en 2015

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

artículo científico publicado en 2008

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

artículo científico publicado en 2011

In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.

artículo científico publicado en 2004

In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer

artículo científico publicado en 2005

Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.

artículo científico publicado en 2016

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

artículo científico publicado en 2004

Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex

artículo científico publicado en 2002

Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

artículo científico publicado en 2022

Integrating the Gynecologic Oncology Group and Gynecologic Cancer SPOREs--a square peg in a round hole or fits like a glove?

scientific article published on 16 February 2007

Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer

artículo científico publicado en 2006

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

artículo científico publicado en 2014

Irinotecan in epithelial ovarian cancer.

artículo científico publicado en 2002

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative ⬇️

artículo científico publicado en 2015

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? ⬇️

artículo científico publicado en 2018

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

artículo científico publicado en 2010

Is micropapillary serous carcinoma for real?

scientific article published on 01 August 2002

KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary

artículo científico publicado en 2018

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

artículo científico publicado en 2013

Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary

artículo científico publicado en 2007

Letter from Houston "So what part of 'stable disease' do you not understand?"

artículo científico publicado en 2009

Limited public knowledge of obesity and endometrial cancer risk: what women know

artículo científico publicado en 2008

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells

artículo científico publicado en 2016

Low grade serous ovarian carcinoma: identifying variations in practice patterns

scientific article published on 01 January 2019

Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

artículo científico publicado en 2005

Low-grade serous carcinoma: new concepts and emerging therapies.

artículo científico

Low-grade serous ovarian cancer: State of the science

scientific article published on 20 January 2020

Low-grade serous ovarian cancer: a unique disease

artículo científico publicado en 2008

Low-grade serous ovarian cancer: expert consensus report on the state of the science

scientific article published on 17 August 2023

Low-grade serous primary peritoneal carcinoma

artículo científico publicado en 2011

Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.

artículo científico publicado en 2006

MEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype

artículo científico publicado en 2020

Management of Rare Ovarian Cancer Histologies

scientific article published on 12 August 2019

Management of borderline ovarian tumours

artículo científico publicado en 2016

Management of ovarian germ cell tumors

artículo científico publicado en 2007

Management of rare epithelial ovarian cancers

Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report

artículo científico publicado en 2004

Mentoring in gynecologic oncology fellowship training and beyond ⬇️

artículo científico publicado el 1 de abril de 2012

Mentorship and productivity among gynecologic oncology fellows

artículo científico publicado en 2003

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

artículo científico publicado en 2007

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases

scientific article published on 01 September 2002

Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer

artículo científico publicado en 2004

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis

artículo científico publicado en 2011

Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review

artículo científico publicado en 2020

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma

artículo científico publicado en 2003

Mucinous Ovarian Carcinoma

artículo científico publicado en 2019

Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes

scientific article published on 20 February 2019

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019

scientific article published on 01 August 2019

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

artículo científico publicado en 2007

Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation

artículo científico publicado en 2009

Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity

artículo científico publicado en 2007

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas

artículo científico publicado en 2015

On-Site Fertility Preservation Services for Adolescents and Young Adults in a Comprehensive Cancer Center

artículo científico publicado en 2016

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2016

Ovarian Cancer, Version 2.2013 ⬇️

artículo científico publicado el 1 de octubre de 2013

Ovarian Cancer, Version 3.2012 ⬇️

artículo científico publicado el 1 de noviembre de 2012

Ovarian Mucinous Neoplasms, Intestinal Type, in Premenopausal Patients, Develop in Abnormal Ovaries

artículo científico publicado en 2020

Ovarian Sex Cord-Stromal Tumors

artículo científico publicado en 2016

Ovarian Yolk Sac Tumors; Does Age Matter?

artículo científico publicado en 2017

Ovarian and extraovarian endometriosis-associated cancer

artículo científico publicado en 2002

Ovarian cancer clinical practice guidelines.

artículo científico publicado en 2004

Ovarian cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Ovarian cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2008

Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?

artículo científico publicado en 2010

Ovarian low-grade serous carcinoma: a comprehensive update

artículo científico

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

artículo científico publicado en 2003

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

artículo científico publicado en 2007

PAX2 Expression in Ovarian Cancer

artículo científico publicado en 2013

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas

artículo científico publicado en 2009

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

artículo científico publicado en 2002

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon

artículo científico publicado en 2005

Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?

artículo científico publicado en 2009

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration

artículo científico publicado en 2015

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

artículo científico publicado en 2004

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

artículo científico publicado en 2012

Peritoneal lesions in guinea pigs treated with hormones

artículo científico publicado en 2002

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

artículo científico publicado en 2010

Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer

artículo científico publicado en 2020

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

artículo científico publicado en 2007

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma

artículo científico publicado en 2015

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

artículo científico publicado en 2018

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

artículo científico publicado en 2005

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube

artículo científico publicado en 2012

Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.

artículo científico publicado en 2003

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer

artículo científico publicado en 2020

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

artículo científico publicado en 2010

Poor survival with wild-type TP53 ovarian cancer?

artículo científico publicado en 2013

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study

artículo científico publicado en 2017

Preoperative Factors Predicting Survival After Secondary Cytoreduction for Recurrent Ovarian Cancer ⬇️

artículo científico publicado el 1 de julio de 2011

Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma

artículo científico publicado en 2005

Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary

artículo científico publicado en 2010

Prevention of ovarian cancer: intraepithelial neoplasia.

artículo científico publicado en 2003

Proceedings from the 9th International Conference on Ovarian Cancer ⬇️

artículo científico publicado el 28 de diciembre de 2011

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

artículo científico publicado en 2006

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.

artículo científico publicado en 2006

Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer

artículo científico publicado en 2007

Prospective evaluation of insulin resistance among endometrial cancer patients

artículo científico publicado en 2011

Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome

artículo científico publicado en 2013

Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residu

artículo científico publicado en 2007

Quality of life and sexual functioning in cervical cancer survivors

artículo científico publicado en 2005

Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study

artículo científico publicado en 2007

Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

artículo científico

RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

artículo científico publicado en 2013

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer

artículo científico publicado en 2023

Rare Gynecologic Tumors: Coming of Age

scientific article published on 01 April 2020

Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study

artículo científico publicado en 2011

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant

artículo científico publicado en 2009

Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model

artículo científico publicado en 2007

Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study

article by David M Gershenson et al published 1 July 2007 in Journal of Clinical Oncology

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

artículo científico publicado en 2002

Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum

artículo científico publicado en 2020

Risk factors for young premenopausal women with endometrial cancer

artículo científico publicado en 2005

Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors

artículo científico publicado en 2017

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

artículo científico publicado en 2011

SEER data: perspective at 10,000 feet

artículo científico publicado en 2008

STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.

artículo científico publicado en 2007

Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?

artículo científico publicado en 2017

Sarcomatoid carcinoma of the cervix.

artículo científico publicado en 2003

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

artículo científico publicado en 2005

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

artículo científico publicado en 2004

Selective activation of ceruloplasmin promoter in ovarian tumors: potential use for gene therapy

artículo científico publicado en 2004

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study ⬇️

artículo científico publicado el 21 de diciembre de 2012

Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy

scientific article published on 01 September 2004

Significance of lymph node ratio on survival of women with borderline ovarian tumors

artículo científico publicado en 2020

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis

artículo científico publicado en 2007

Specific keynote: molecular therapeutics in ovarian cancer

artículo científico publicado en 2003

Stage IIIC ovarian/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses

artículo científico publicado en 2014

Stress hormone-mediated invasion of ovarian cancer cells

artículo científico publicado en 2006

Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.

artículo científico publicado en 2005

Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature

artículo científico publicado en 2020

Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer

artículo científico publicado en 2014

Survival in Women With Grade 1 Serous Ovarian Carcinoma ⬇️

artículo científico publicado el 1 de agosto de 2013

Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases

artículo científico publicado en 2004

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

artículo científico publicado en 2010

The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary

artículo científico publicado en 2006

The Life and Times of Low-Grade Serous Carcinoma of the Ovary ⬇️

artículo científico publicado el 1 de enero de 2013

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy

artículo científico publicado en 2020

The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors

artículo científico publicado en 2005

The activity of taxanes in the treatment of sex cord-stromal ovarian tumors

artículo científico publicado en 2004

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

artículo científico publicado en 2011

The association of benign and malignant ovarian adenofibromas with breast cancer and thyroid disorders

artículo científico publicado en 2002

The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer

artículo científico publicado en 2006

The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary

scientific article published on January 2007

The future of gynecologic oncology: Are we headed for super-specialization? ⬇️

artículo científico publicado el 4 de mayo de 2011

The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes

artículo científico publicado en 2022

The heterogeneity of epithelial ovarian cancer: getting it right

artículo científico publicado en 2010

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

artículo científico publicado en 2011

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.

artículo científico publicado en 2013

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

artículo científico publicado en 2006

The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance

scientific article published on 22 July 2020

The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer

artículo científico publicado en 2014

The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas

scientific article published on 01 November 2004

Time for action: a "sea change" in treatment strategies for rare types of epithelial ovarian cancer

artículo científico publicado en 2007

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

artículo científico publicado en 2022

Treatment of Ovarian Cancer in Young Women ⬇️

artículo científico publicado el 1 de marzo de 2012

Treatment of Rare Epithelial Ovarian Tumors

artículo científico publicado en 2018

Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro

artículo científico publicado en 2002

Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?

artículo científico publicado en 2002

Trends of low-grade serous ovarian carcinoma in the United States

artículo científico publicado en 2018

Unmasking the complexities of mucinous ovarian carcinoma

artículo científico publicado en 2010

Update on the management of ovarian germ cell tumors.

artículo científico publicado en 2005

Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all.

artículo científico publicado en 2014

Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer

artículo científico publicado en 2006

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

artículo científico publicado en 2003

Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary

artículo científico publicado en 2014

Women With Synchronous Primary Cancers of the Endometrium and Ovary: Do They Have Lynch Syndrome?

artículo científico publicado en 2005

[IV. Current Status and Future Perspectives in Low-Grade Serous Cancer of the Ovary]

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma

scientific article published on 01 March 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda